Prediagnostic White Blood Cell DNA Methylation and Risk of Breast Cancer in the Prostate Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) Cohort.

Susan R SturgeonDavid A SelaEva P BrowneJonah EinsonAsha RaniMohamed HalabiThomas KaniaAndrew KeezerRaji Balasubramanian Regina G ZieglerCatherine SchairerKarl T KelseyKathleen F Arcaro

Published in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2021)

The link between prediagnostic WBC DNA methylation marks and breast cancer, if any, is poorly understood.

Keyphrases

dna methylation
genome wide
gene expression
prostate cancer
clinical trial
study protocol
cell therapy
phase iii
randomized controlled trial
phase ii
breast cancer risk
copy number
bone marrow
young adults
mesenchymal stem cells